STATEMENT REGARDING COVID-19

Extraordinary times require extraordinary measures. The current coronavirus crisis has prompted us to take action on the upcoming XII Barcelona-Pittsburgh Conference edition.

After conscientiously studying all the scenarios and given the uncertain and risky situation, in which many countries already prevent or advise against travelling, we consider that the best option is to postpone the conference to the 19-21 May 2021.

It is our duty to live up to the confidence that the experts and attendees have placed in us and our organization. We are willing to assume the cancellation of the conference to prioritize the health and safety of our speakers and chairs, attendees and the conference team.

The scientific committee of the conference has always had the firm will to design a conference that highlights the hard work of the speakers and promotes networking to build synergies and create networks that help science grow. That is why we do not want to lose the benefits of a face-to-face meeting and we hope you can already set in your agenda the dates for the Barcelona-Pittsburgh 2021.

As much as we are saddened by this situation, we do believe that in difficult times safety must come first.

Who we are

Fundació ACE – Barcelona Alzheimer’s Treatment & Research Center and the Alzheimer’s disease Research Center (ADRC) of the University Of Pittsburgh School Of Medicine organize since 1998 the biennial Barcelona–Pittsburgh Conference.

What we do

We work to offer a quality conference bringing together panelists of recognized national and international scientific prestige; and creating an interactive space related to neuroscience, with the ultimate objective of benefiting the affected people and their families.

Why us?

Over the years, the Barcelona – Pittsburgh Conference has become a reference in the field of dementia. The conference is aimed at all professionals working with dementia, both from a medical and a socio-legal perspective.

Speakers

Speakers area

  • Mercè Boada

    CMO. Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • Agustín Ruiz

    CSO. Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • Victor Villemagne

    Associate Professor of Medicine, The University of Melbourne. Deputy Director, Molecular Imaging Research, Austin Health. Melbourne, Australia.

  • Sergi Valero

    Medical Psychology Department Head. Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • Sonia Moreno Grau

    Postdoctoral Researcher at Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • José Luis Molinuevo

    Neurologist, Scientific Director of the Alzheimer's Prevention Program at the BarcelonaBeta Brain Research Center (BBRC)

  • Alba Benaque

    CEO. Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • Michael J. Detke

    Chief Medical Officer of Cortexyme, a clinical-phase biotechnology company developing treatments of AD and other neurodegenerative disorders.

  • Joshua C. Bis

    Genetic epidemiologist at the University of Washington Cardiovascular Health Research Unit. Washington, USA

  • Cornelia Van Duijn

    Professor of Genetic Epidemiology at the Nuffield Department of Population Health, University of Oxford and a Fellow of St Cross College, University of Oxford.

  • Robert Fabregat

    general director of Health Research and Innovation. Generalitat de Catalunya.

  • Pascual Sánchez-Juan

    Neurologist and head of the Memory Unit at University Hospital Marques de Valdecilla

  • Pilar Cañabate

    Head of the Social Work Unit and Coordinator of Social Research. Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • Vincent Doré

  • Arno de Wilde

    Neurology resident and researcher at the Alzheimer Center and Department of Neurology of the Amsterdam UMC

  • Suzanne Hendrix

  • Lew Kuller

  • Myriam Fornage

  • Claudia L. Satizabal Barrera

  • Santos Mañes

  • Rafael Blesa

    Director of the Neurology Department at the Hospital de la Santa Creu i Sant Pau, Barcelona.

  • Geoffrey Kerchner

    Roche

  • Pierre Meulien

  • Oscar López

    University of Pittsburgh, Scientific Committee of Fundació ACE

  • James T. Becker

    Professor of Psychiatry, Neurology and Psychology, University of Pittsburgh

  • Sudha Seshadri

    Professor of Neurology, Psychiatry and Cellular and Integrative Physiology, the Robert R. Barker Distinguished University Chair and Founding Director, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, San Antonio, Texas.

  • Frank Jessen

    University of Cologne

  • Steven Braithwaite

    Chief Scientific Officer, Alkahest, San Carlos, CA, USA

  • Marta Marquié

    Deputy Head of Clinical Research. Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • Carla Abdelnour

    Deputy Head of the Clinical Trials Unit, coordinator of Fundació ACE Social Technology And Robotics Reseach (FACESTARR). Research Center and Memory Clinic. Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona – Universitat Internacional de Catalunya, Barcelona, Spain.

  • Sven van der Lee

    Medical doctor and postdoctoral researcher at the Alzheimer center of the VU University medical center (Amsterdam, The Netherlands).

  • Bryan Strange

    The Vallecas Project. Fundación CIEN.

  • Carolin Schwegler

    Research Associate, Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health (ceres), University of Cologne, Germany

  • Björn Schmitz-Luhn

    General Manager, ceres – Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health, University of Cologne; Adjunct Professor, University of Economics and Management, Essen, Germany.

  • Jean Charles Lambert

    Inserm Research Director. Head of team 3, UMR1167 “Search for molecular determinants of Alzheimer’s disease and related disorders”

  • Xavier Corbella

    Vice Dean, Faculty of Medicine at Universitat Internacional de Catalunya (UIC Barcelona)

  • Annie Cohen

    Associate Professor of Psychiatry, University of Pittsburgh School of Medicine. Associate Director, University of Pittsburgh Alzheimer’s disease research center, Neuroimaging Core

  • Christopher Butler

    Associate Professor in Clinical Neurosciences and Principle Investigator, Memory Research Group, University of Oxford, UK.

  • Adela Orellana

    Head of Laboratory. Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • Jesús Ávila

    Professor and Scientific Director of CIBERNED.

  • Antonio Páez

    Grífols

  • Robert Sweet

    UPMC Professor of Psychiatric Neuroscience and Professor of Neurology, University of Pittsburgh. Director, Clinical Core, University of Pittsburgh Alzheimer Disease Research Center. Pittsburgh, PA, USA

  • Alfredo Ramírez

    Department of Psychiatry and Psychotherapy, University of Bonn

  • Lluís Tárraga Mestre

    Executive advisor. Research Center and Memory Clinic. Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Universitat Internacional de Catalunya, Spain

  • Gerard Piñol

    Hospital Universitari de Santa Maria, Lleida / Universitat de Lleida

  • Milos Ikonomovic

    Associate Professor of Neurology and Psychiatry, University of Pittsburgh School of Medicine; Geriatric Research Education and Clinical Center, VA Pittsburgh HS, Pittsburgh, PA, U.S.A.

  • Jean Georges

  • Gill Farrar

  • Ayda Rostamzadeh

    Attending physician at the Department of Psychiatry and Psychotherapy, University Hospital of Cologne. Cologne, Germany

  • Albert Lleó Bisa

    Neurologist and director of the Memory Disorders Unit of the Neurology Department at Hospital de Sant Pau (Barcelona).

  • Christiane Woopen

    Professor for Ethics and Theory of Medicine and Executive Director of the Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health (ceres), University of Cologne.

Program

View full program
20 May 2020
Workshop on Ethics
20 May 2020
Workshop on Behavioral symptoms in Dementia
21 May 2020
XII BCN-PIT
22 May 2020
XII BCN-PIT
15:00 - 16:30

REGISTRATION

16:30 - 17:00

KEY NOTE LECTURE – Ethics of Predictive Diagnostics: Insights from the PreDADQoL-project

Christiane Woopen
Chair: C Schwegler
17:00 - 18:00

PANEL – ETHICS

Chair: B Schmitz-Luhn, M Boada
17:00 - 17:15

Biomarker-based risk estimation in MCI and SCD

Arno de Wilde
17:15 - 17:30

Ethical challenges related to pre-dementia diagnosis of AD and dementia risk estimation in clinical practice

Frank Jessen
17:30 - 17:45

Data and experience from the PreDADQoL project

Ayda Rostamzadeh
17:45 - 18:00

Quality of Life after biomarkers: lights and shadows

Pilar Cañabate
18:00 - 18:30

DISCUSSION

15:00 - 16:30

REGISTRATION

16:30 - 17:00

KEY NOTE LECTURE

Christopher Butler
Chair: S Valero
17:00 - 18:00

PANEL – BEYOND NPI

Chair: C Butler
17:00 - 17:15

Título/Title

Gerard Piñol
17:15 - 17:30

Título/Title

Robert Sweet
17:30 - 17:45

Interaction of neuropsychiatric symptoms with APOE4 and conversion to dementia in MCI patients in a Memory Clinic

Sergi Valero
17:45 - 18:00

Título/Title

18:00 -18:30

DISCUSSION

07:30 - 08:30

REGISTRATION

08:30 – 09:30

PANEL – BIOMARKERS

Chairs: A Orellana, A Lleó
08:30 - 08:50

OCT

Marta Marquié
08:50 - 09:10

Implementation of CSF AD biomarkers in a Memory Unit: a 10-year perspective

Albert Lleó Bisa
09:10 - 09:30

PROTEOMICA

Steven Braithwaite
09:30-10:00

KEY NOTE LECTURE

Lew Kuller
10:00 – 11:00

PANEL – PERIPHERAL HYPOTHESIS

Chair: M Boada
10:00 – 10:20

Título/Title

Antonio Páez
10:20 – 10:40

Título/Title

Santos Mañes
10:40 – 11:00

Título/Title

Oscar López
11:00 – 11:30

Coffee Break

11:30 – 12:00

KEY NOTE LECTURE – Amyloid, tau and neuroinflammation imaging in Alzheimer’s disease

Victor Villemagne
Chair: O Lopez
12:00 - 13:00

PANEL – NEUROIMAGING

Chair: V Villemagne
12:00 - 12:20

Neuropathology-neuroimaging correlation studies

Milos Ikonomovic
12:20 – 12:40

Improved imaging quantification approaches

Vincent Doré
12:40 – 13:00

Insights into late-onset AD pathology using PET imaging in individuals with APP overproduction

Annie Cohen
13:00 – 13:30

OPENING FUNDACIÓ ACE’S BOARD OF TRUSTEES 6TH “FUNDACIÓ ACE. JOAN BOADA & MERCÈ ROVIRA” AWARD

Robert Fabregat
Introduced by: A Ruiz
13:30 - 14:30

Lunch

14:30 - 15:00

KEY NOTE LECTURE

Sudha Seshadri
Chair: A Ruiz
15:00 - 16:00

PANEL – CHARGE

Chair: O López
15:00 - 15:15

Gene Discovery for Multifactorial Disease: Promises and Challenges for Etiology & Precision Medicine

Myriam Fornage
15:15 - 15:30

Gut microbiome and cognitive function

Cornelia Van Duijn
15:30 - 15:45

Título/Title

Claudia L. Satizabal Barrera
15:45 - 16:00

Título/Title

Joshua C. Bis
16:00 - 16:30

KEY NOTE LECTURE

Carla Abdelnour
Chair: M Boada
16:30 - 17:00

Coffee Break

17:00 - 18:00

PANEL – NEW TREATMENTS

Chairs: M Boada, C Abdelnour
17:00 - 17:20

Título/Title

Suzanne Hendrix
17:20 - 17:40

Initiation ot the Phase 2/3 GAIN trial of COR388, a novel bacterial virulence factor inhibitor for the treatment of Alzheimer’s Disease based on Phase 1 a/b safety, PK, biomarker and efficacy data

Michael J. Detke
17:40 - 18:00

Título/Title

18:00 - 19:00

PANEL – NEW TREATMENTS 2

Chairs: M Boada, C Abdelnour
18:00 - 18:20

Título/Title

Geoffrey Kerchner
18:20 - 18:40

Título/Title

18:40 - 19:00

Título/Title

08:30 - 09:00

KEY NOTE LECTURE

Frank Jessen
Chair: M Boada
09:00 - 10:00

PANEL – LOOKING FOR ASYNTOMATICS: LEARNINGS

Chair: M Boada
09:00 - 09:15

Proyecto Vallecas

Bryan Strange
09:15 - 09:30

FACEHBI

Marta Marquié
09:30 - 09:45

Título/Title

José Luis Molinuevo
09:45 - 10:00

The Natural History of Alzheimer’s Disease in adults with Down Syndrome: a cross-sectional study

Rafael Blesa
10:00 - 10:30

KEY NOTE LECTURE

Pierre Meulien
Chair: M Boada
10:30 - 11:30

PANEL – IMI

Chairs: J Georges
10:30 - 10:45

EPAD

José Luis Molinuevo
10:45 - 11:00

IMI2-ADAPTED: Alzheimer’s disease apolipoprotein pathology for treatment elucidation and development

Agustín Ruiz
11:00 - 11:15

MOPEAD

Mercè Boada
11:15 - 11:30

AMYPAD

Gill Farrar
11:30 - 12:00

Coffee Break

12:00 - 12:30

KEY NOTE LECTURE – Genetics of Alzheimer’s disease: where we are and where we are going

Jean Charles Lambert
Chair: S Moreno-Grau
12:30 - 13:30

PANEL – GENETICS

Chairs: Lambert, Moreno-Grau
12:30 - 12:45

The Gr@ACE Project Update

Sonia Moreno Grau
12:45 - 13:00

EADB

Alfredo Ramírez
13:00 - 13:15

VUMC Genetics

Sven van der Lee
13:15 - 13:30

A Story of TAU, the Basques and the Mediterranean

Pascual Sánchez-Juan
13:30 - 14:00

CLOSING LECTURE – Investigation of the Human Connectome in Aging and Dementia

James T. Becker
Chair: L Tárraga
14:00 - 14:30

SCIENTIFIC ADVISORY BOARD

Mercè Boada, Fundació ACE, Spain.
Agustín Ruiz, Fundació ACE, Spain.
Óscar López, University of Pittsburgh, USA.
Jesús Ávila, Centro de Biología Molecular Severo Ochoa, Spain.
Cornelia Van Duijn, University of Oxford, UK.
James Becker, University of Pittsburgh, USA.
Lluís Tárraga, Fundació ACE, Spain.
14:00 - 14:30

CLOSING CEREMONY

Chairs: A Benaque, L Tárraga, A Ruiz
 
 
 

 

Location

World Trade Center
Edif. Este, Moll de Barcelona, s/n, 08039 Barcelona
+34 93 444 73 18bcnpit@fundacioace.org

Register online

Sponsors

Register online

Personal information
Professional information
I want to attend

If you are a member of the Societat Catalana de Neurologia (SCN), Ciberned, EAIA or you can have some discount for the Conference, please contact bcnpit@fundacioace.org.
During the Conference, pictures and footage will be taken and used for promotion of other events.